AKAdrian Koch

Adrian Koch

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Adrian Koch has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    New Oleoyl Hybrids of Natural Antioxidants: Synthesis and In Vitro Evaluation as Inducers of Apoptosis in Colorectal Cancer Cells

    by Gabriele Carullo, Sarah Mazzotta, Adrian Koch, Kristin M. Hartmann, Oliver Friedrich, Daniel F. Gilbert, Margarita Vega-Holm, Regine Schneider-Stock, Francesca Aiello

    Nowadays, the beneficial role of a healthy lifestyle, particularly emphasizing the quality of foods and cancer management, is accepted worldwide. Polyphenols and oleic acid play a key role in this context, but are still scarcely used as anti-cancer agents due to their bio-accessibility limits. Therefore, we aimed to synthesize a set of new oleoyl-hybrids of quercetin, morin, pinocembrin, and catechin to overcome the low bioavailability of polyphenols, throughout a bio-catalytic approach using pancreatic porcine lipase as a catalyst. The in vitro assays, using a wide panel of human cancer cell lines showed, mainly for two novel regioisomer oleoyl-hybrids of quercetin, a remarkable increase in apoptotic cell populations. We suggested that the DNA damage shown as ɣH2AX signals might be the major cause of apoptotic cell death. Finally, we demonstrated convincing data about two novel polyphenol-based hybrids displaying a highly selective anti-cancer cytotoxicity and being superior compared to their reference/parental compounds.


  • Open Access

    New Oleoyl Hybrids of Natural Antioxidants: Synthesis and in vitro Evaluation as Inducers of Apoptosis in Colorectal Cancer Cells

    by Francesca Aiello, Gabriele Carullo, Sarah Mazzotta, Adrian Koch, Kristin M. Hartmann, Oliver Friedrich, Daniel Gilbert, Margarita Vega-Holm, Regine Schneider-Stock

    Nowadays the beneficial role of a healthy lifestyle, particularly emphasizing the quality of foods and cancer management, is worldwide accepted. Polyphenols and oleic acid play a key role in this context, but are still scarcely used as anti-cancer agents due to their bio-accessibility limits. Thus, we aimed to synthesize a set of new oleoyl-hybrids of quercetin, morin, pinocembrin and catechin, to overcome the low bioavailability of polyphenols, throughout a bio-catalytic approach using porcine pancreatic lipase as catalyst. The in vitro assays, using a wide panel of human cancer cell lines, showed, mainly for two novel regioisomer oleoyl-hybrids of quercetin, a remarkable increase in apoptotic cell populations. We suggest that DNA damage shown as ɣH2AX signals might be the major cause of apoptotic cell death. Finally, we demonstrate convincing data about two novel polyphenol-based hybrids displaying highly selective anti-cancer cytotoxicity and being superior compared to their reference/parental compounds.

  • Open Access

    Defective Autophagosome Formation in p53-Null Colorectal Cancer Reinforces Crocin-Induced Apoptosis

    by Amr Amin, Khuloud Bajbouj, Adrian Koch, Muktheshwar Gandesiri, Regine Schneider-Stock

    Crocin, a bioactive molecule of saffron, inhibited proliferation of both HCT116 wild-type and HCT116 p53−/− cell lines at a concentration of 10 mM. Flow cytometric analysis of cell cycle distribution revealed that there was an accumulation of HCT116 wild-type cells in G1 (55.9%, 56.1%) compared to the control (30.4%) after 24 and 48 h of crocin treatment, respectively. However, crocin induced only mild G2 arrest in HCT116 p53−/− after 24 h. Crocin induced inefficient autophagy in HCT116 p53−/− cells, where crocin induced the formation of LC3-II, which was combined with a decrease in the protein levels of Beclin 1 and Atg7 and no clear p62 degradation. Autophagosome formation was not detected in HCT116 p53−/− after crocin treatment predicting a nonfunctional autophagosome formation. There was a significant increase of p62 after treating the cells with Bafilomycin A1 (Baf) and crocin compared to crocin exposure alone. Annexin V staining showed that Baf-pretreatment enhanced the induction of apoptosis in HCT116 wild-type cells. Baf-exposed HCT116 p53−/− cells did not, however, show any enhancement of apoptosis induction despite an increase in the DNA damage-sensor accumulation, γH2AX indicating that crocin induced an autophagy-independent classical programmed cell death.